Aetna to drop copays on heart attack drugs

Aetna plans to eliminate copays on drugs that help prevent heart attacks after a study showed patients took their medicines and were healthier when there were no out-of-pocket costs for their treatments, reports FiercePracticeManagement. "While the savings wasn't considered statistically significant, it showed it didn't cost the insurer more to eliminate the co-pays," said Dr. Niteesh Choudhry, lead study author and researcher at Brigham and Women's Hospital. Accoding to Dr. Lonny Reisman, Aetna's chief medical officer and an author of the study published in the New England Journal of Medicine, the insurer is considering doing do so for other chronic conditions such as diabetes and chronic lung disease. Article

Suggested Articles

Provider groups and health systems are clamoring for HHS to provide direct assistance to cash-strapped hospitals now.

Kaiser Permanente is offering its members free access to Livongo's mental health app myStrength to help address increased stress and anxiety.

Zocdoc has added telehealth appointments to its platform in response to the spike in demand for virtual care.